SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha and beta proteins (a+b) (23004)
(-)
Fold: Zincin-like (701)
(-)
Superfamily: Metalloproteases (zincins), catalytic domain (647)
(-)
Family: Anthrax toxin lethal factor, N- and C-terminal domains (10)
(-)
Protein domain: Anthrax toxin lethal factor, N- and C-terminal domains (9)
(-)
Anthrax bacillus (Bacillus anthracis) [TaxId: 1392] (9)
1J7NA:27-263; A:551-773; B:27-263; B:551-776ANTHRAX TOXIN LETHAL FACTOR
1JKYA:29-263; A:551-776CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR (LF): WILD-TYPE LF COMPLEXED WITH THE N-TERMINAL SEQUENCE OF MAPKK2
1PWPA:30-263; A:551-776; B:31-263; B:551-776CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR COMPLEXED WITH SMALL MOLECULE INHIBITOR NSC 12155
1PWQA:27-263; A:551-776; B:27-263; B:551-776CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH THIOACETYL-TYR-PRO-MET-AMIDE, A METAL-CHELATING PEPTIDYL SMALL MOLECULE INHIBITOR
1PWUA:30-263; A:551-776; B:33-263; B:551-776CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR COMPLEXED WITH (3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE), A KNOWN SMALL MOLECULE INHIBITOR OF MATRIX METALLOPROTEASES.
1PWVA:27-263; A:551-776; B:33-263; B:551-776CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR WILD-TYPE PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE.
1PWWA:29-263; A:551-776; B:28-263; B:551-776CRYSTAL STRUCTURE OF ANTHRAX LETHAL FACTOR ACTIVE SITE MUTANT PROTEIN COMPLEXED WITH AN OPTIMISED PEPTIDE SUBSTRATE IN THE PRESENCE OF ZINC.
1YQYA:551-778STRUCTURE OF B. ANTHRAX LETHAL FACTOR IN COMPLEX WITH A HYDROXAMATE INHIBITOR
1ZXVA:27-263; A:551-776; B:27-263; B:551-776X-RAY CRYSTAL STRUCTURE OF THE ANTHRAX LETHAL FACTOR BOUND TO A SMALL MOLECULE INHIBITOR, BI-MFM3, 3-{5-[5-(4-CHLORO-PHENYL)-FURAN-2-YLMETHYLENE]-4-OXO-2-THIOXO-THIAZOLIDIN-3-YL}-PROPIONIC ACID.
(-)
Protein domain: automated matches (1)
(-)
Anthrax bacillus (Bacillus anthracis) [TaxId: 1392] (1)
4DV8A:551-776ANTHRAX LETHAL FACTOR METALLOPROTEINASE IN COMPLEX WITH THE HYDROXAMIC ACID BASED SMALL MOLECULE PT8421
(-)
Family: Astacin (8)
(-)
Protein domain: Astacin (8)
(-)
European fresh water crayfish (Astacus astacus) [TaxId: 6715] (8)
1ASTA:STRUCTURE OF ASTACIN AND IMPLICATIONS FOR ACTIVATION OF ASTACINS AND ZINC-LIGATION OF COLLAGENASES
1IAAA:CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY
1IABA:CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY
1IACA:REFINED 1.8 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF ASTACIN, A ZINC-ENDOPEPTIDASE FROM THE CRAYFISH ASTACUS ASTACUS L. STRUCTURE DETERMINATION, REFINEMENT, MOLECULAR STRUCTURE AND COMPARISON WITH THERMOLYSIN
1IADA:REFINED 1.8 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF ASTACIN, A ZINC-ENDOPEPTIDASE FROM THE CRAYFISH ASTACUS ASTACUS L. STRUCTURE DETERMINATION, REFINEMENT, MOLECULAR STRUCTURE AND COMPARISON TO THERMOLYSIN
1IAEA:CRYSTAL STRUCTURES, SPECTROSCOPIC FEATURES, AND CATALYTIC PROPERTIES OF COBALT(II), COPPER(II), NICKEL(II), AND MERCURY(II) DERIVATIVES OF THE ZINC ENDOPEPTIDASE ASTACIN. A CORRELATION OF STRUCTURE AND PROTEOLYTIC ACTIVITY
1QJIA:STRUCTURE OF ASTACIN WITH A TRANSITION-STATE ANALOGUE INHIBITOR
1QJJA:STRUCTURE OF ASTACIN WITH A HYDROXAMIC ACID INHIBITOR
(-)
Family: automated matches (37)
(-)
Protein domain: automated matches (37)
(-)
African clawed frog (Xenopus laevis) [TaxId: 8355] (1)
4GAAA:206-457; B:206-457STRUCTURE OF LEUKOTRIENE A4 HYDROLASE FROM XENOPUS LAEVIS COMPLEXED WITH INHIBITOR BESTATIN
(-)
Bacillus subtilis [TaxId: 1423] (1)
3HQ2A:; B:BSUCP CRYSTAL STRUCTURE
(-)
Clostridium botulinum [TaxId: 1491] (5)
2FPQA:CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE D LIGHT CHAIN
2QN0A:STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 LIGHT CHAIN PROTEASE
2W2DB:449-547; D:449-547CRYSTAL STRUCTURE OF A CATALYTICALLY ACTIVE, NON-TOXIC ENDOPEPTIDASE DERIVATIVE OF CLOSTRIDIUM BOTULINUM TOXIN A
2XHLB:458-549STRUCTURE OF A FUNCTIONAL DERIVATIVE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE B
3DEBA:CRYSTAL STRUCTURE OF APO FORM (ZINC REMOVED) OF THE BOTULINUM NEUROTOXIN TYPE C LIGHT CHAIN
(-)
Clostridium tetani [TaxId: 1513] (2)
1YVGA:STRUCTURAL ANALYSIS OF THE CATALYTIC DOMAIN OF TETANUS NEUROTOXIN
1Z7HA:2.3 ANGSTROM CRYSTAL STRUCTURE OF TETANUS NEUROTOXIN LIGHT CHAIN
(-)
Clostridium tetani [TaxId: 212717] (1)
4J1LA:MUTANT ENDOTOXIN TENT
(-)
Human (Homo sapiens) [TaxId: 9606] (22)
2C6FA:; B:STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN
2C6NA:; B:STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN WITH LISINOPRIL
2DDYA:SOLUTION STRUCTURE OF MATRILYSIN (MMP-7) COMPLEXED TO CONSTRAINT CONFORMATIONAL SULFONAMIDE INHIBITOR
2XYDA:; B:HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE
3B8ZA:; B:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 (AGGRECANASE-2)
3DWBA:STRUCTURE OF HUMAN ECE-1 COMPLEXED WITH PHOSPHORAMIDON
3EDGA:CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN 1 PROTEASE DOMAIN
3EDHA:CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN 1 PROTEASE DOMAIN IN COMPLEX WITH PARTIALLY BOUND DMSO
3EDIA:CRYSTAL STRUCTURE OF TOLLOID-LIKE PROTEASE 1 (TLL-1) PROTEASE DOMAIN
3HY7A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH MARIMASTAT
3HY9A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
3HYGA:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
3LJTA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ADAMTS-5 IN COMPLEX WITH AN AMINO-2-INDANOL COMPOUND
3MDJA:255-529; B:255-529; C:255-529ER AMINOPEPTIDASE, ERAP1, BOUND TO THE ZINC AMINOPEPTIDASE INHIBITOR, BESTATIN
3NXQA:; B:ANGIOTENSIN CONVERTING ENZYME N DOMAIN GLYCSOYLATION MUTANT (NDOM389) IN COMPLEX WITH RXP407
3QNFA:255-529; B:255-529; C:255-529CRYSTAL STRUCTURE OF THE OPEN STATE OF HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 ERAP1
3SE6A:272-546; B:272-546CRYSTAL STRUCTURE OF THE HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2
4BXKA:; B:CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DOMAIN-SPECIFIC INHIBITOR
4BZSA:; B:HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH K-26
4CA6A:; B:HUMAN ANGIOTENSIN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI
4DD8A:; B:; C:; D:ADAM-8 METALLOPROTEINASE DOMAIN WITH BOUND BATIMASTAT
4JBSA:272-546; B:272-546CRYSTAL STRUCTURE OF THE HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE INHIBITOR.
(-)
Mycobacterium tuberculosis [TaxId: 83332] (1)
3ZUKA:; B:CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ZINC METALLOPROTEASE ZMP1 IN COMPLEX WITH INHIBITOR
(-)
Protobothrops mucrosquamatus [TaxId: 103944] (1)
4J4MA:; B:CRYSTAL STRUCTURE OF TM-1, A TRIMERESURUS MUCROSQUAMATUS VENOM METALLOPROTEINASE
(-)
Thermoplasma acidophilum [TaxId: 273075] (1)
3Q7JA:171-414; B:171-414ENGINEERED THERMOPLASMA ACIDOPHILUM F3 FACTOR MIMICS HUMAN AMINOPEPTIDASE N (APN) AS A TARGET FOR ANTICANCER DRUG DEVELOPMENT
(-)
Thermus thermophilus HB8 [TaxId: 300852] (1)
1WGZ  [entry was replaced by entry 5WVU without any SCOP domain information]
(-)
Thermus thermophilus [TaxId: 262724] (1)
3HOAA:; B:CRYSTAL STRUCTURE OF THE THERMUS THERMOPHILUS M32 CARBOXYPEPTIDASE
(-)
Family: Caur0242-like (1)
(-)
Protein domain: Uncharacterized protein Caur0242 (1)
(-)
Chloroflexus aurantiacus [TaxId: 1108] (1)
3CMNA:43-391CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE WITH A NOVEL FOLD FROM CHLOROFLEXUS AURANTIACUS
(-)
Family: Clostridium neurotoxins, catalytic domain (65)
(-)
Protein domain: automated matches (23)
(-)
Clostridium botulinum [TaxId: 1491] (19)
1ZKWA:; B:CRYSTAL STRUCTURE OF ARG347ALA MUTANT OF BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
1ZKXA:; B:CRYSTAL STRUCTURE OF GLU158ALA/THR159ALA/ASN160ALA- A TRIPLE MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
1ZL5A:; B:CRYSTAL STRUCTURE OF GLU335GLN MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
1ZL6A:; B:CRYSTAL STRUCTURE OF TYR350ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
1ZN3A:; B:CRYSTAL STRUCTURE OF GLU335ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E
2A8AA:CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F LIGHT CHAIN
2A97A:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F
2ISEA:; B:BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM A
2ISGA:; B:BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM B
2ISHA:; B:BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM C
3BWIA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH AN ACETATE ION BOUND AT THE ACTIVE SITE
3C88A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGC
3C89A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGM
3C8AA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGL
3C8BA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGI
3FIEA:; B:CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH1)
3FIIA:CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH2)
4EL4A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S/C165S DOUBLE MUTANT
4ELCA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134 MUTANT WITH MTSEA MODIFIED CYS-165
(-)
Clostridium botulinum [TaxId: 441771] (4)
3QIXA:; B:CRYSTAL STRUCTURE OF BONT/A LC WITH ZINC BOUND
3QIYA:CRYSTAL STRUCTURE OF BONT/A LC COMPLEXED WITH HYDROXAMATE-BASED INHIBITOR PT-1
3QIZA:CRYSTAL STRUCTURE OF BONT/A LC COMPLEXED WITH HYDROXAMATE-BASED INHIBITOR PT-2
3QJ0A:CRYSTAL STRUCTURE OF BONT/A LC COMPLEXED WITH HYDROXAMATE-BASED INHIBITOR PT-3
(-)
Protein domain: Botulinum neurotoxin (42)
(-)
Clostridium botulinum, serotype A [TaxId: 1491] (23)
1E1HA:,B:; C:,D:CRYSTAL STRUCTURE OF RECOMBINANT BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN, SELF-INHIBITING ZN ENDOPEPTIDASE.
1XTFA:; B:NEUROTOXIN BONT/A E224Q Y366F MUTANT
1XTGA:CRYSTAL STRUCTURE OF NEUROTOXIN BONT/A COMPLEXED WITH SYNAPTOSOMAL-ASSOCIATED PROTEIN 25
2G7KA:; B:STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN, SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
2G7NA:STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
2ILPA:; B:CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY 4-CHLOROCINNAMIC HYDROXAMATE
2IMAA:; B:CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY 2,4-DICHLOROCINNAMIC HYDROXAMATE
2IMBA:; B:CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY L-ARGININE HYDROXAMATE
2IMCA:; B:CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN, RESIDUES 1-424
2NYYA:2-547CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
3BOKA:STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A APO-ENZYME
3BONA:STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH ZN2+ COFACTOR BOUND
3BOOA:3-419STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH AN INHIBITORY PEPTIDE BOUND
3BTAA:1-546CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A
3DS9A:A POTENT PEPTIDOMIMETIC INHIBITOR OF BOTULINUM NEUROTOXIN SEROTYPE A HAS A VERY DIFFERENT CONFORMATION THAN SNAP-25 SUBSTRATE
3DSEA:A POTENT PEPTIDOMIMETIC INHIBITOR OF BOTULINUM NEUROTOXIN SEROTYPE A HAS A VERY DIFFERENT CONFORMATION THAN SNAP-25 SUBSTRATE
3NF3A:CRYSTAL STRUCTURE OF BONT/A LC WITH JTH-NB-7239 PEPTIDE
3QW5A:CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RRGF
3QW6A:CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RYGC
3QW7A:CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RRFC
3QW8A:CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR CRGC
4EJ5A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A WILD-TYPE
4HEVA:; B:CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY ADAMANTANE HYDROXAMATE
(-)
Clostridium botulinum, serotype B [TaxId: 1491] (16)
1EPWA:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B
1F31A:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE
1F82A:BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN
1G9AA:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)
1G9BA:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)
1G9CA:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)
1G9DA:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)
1I1EA:1-533CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN
1S0BA:1-533CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0
1S0CA:1-533CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0
1S0DA:1-533CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5
1S0EA:1-533CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0
1S0FA:1-533CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0
1S0GA:1-533CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM
2ETFA:; B:CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN
2NP0A:1-533CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN
(-)
Clostridium botulinum, serotype E [TaxId: 1491] (2)
1T3AA:; B:CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E CATALYTIC DOMAIN
1T3CA:; B:CLOSTRIDIUM BOTULINUM TYPE E CATALYTIC DOMAIN E212Q MUTANT
(-)
Clostridium butyricum [TaxId: 1492] (1)
3D3XA:; B:CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE E CATALYTIC DOMAIN IN COMPLEX WITH SNAP-25 SUBSTRATE PEPTIDE
(-)
Family: Fungal zinc peptidase (5)
(-)
Protein domain: Fungal zinc peptidase (5)
(-)
Aspergillus oryzae, deuterolysin [TaxId: 5062] (1)
1EB6A:DEUTEROLYSIN FROM ASPERGILLUS ORYZAE
(-)
Grifola frondosa [TaxId: 5627] (4)
1G12A:ZINC PEPTIDASE FROM GRIFOLA FRONDOSA
1GE5A:ZINC PEPTIDASE FROM GRIFOLA FRONDOSA
1GE6A:ZINC PEPTIDASE FROM GRIFOLA FRONDOSA
1GE7A:; B:ZINC PEPTIDASE FROM GRIFOLA FRONDOSA
(-)
Family: Leishmanolysin (1)
(-)
Protein domain: Leishmanolysin (1)
(-)
Leishmania major [TaxId: 5664] (1)
1LMLA:LEISHMANOLYSIN
(-)
Family: Matrix metalloproteases, catalytic domain (199)
(-)
Protein domain: automated matches (32)
(-)
Human (Homo sapiens) [TaxId: 9606] (32)
1Z3JA:SOLUTION STRUCTURE OF MMP12 IN THE PRESENCE OF N-ISOBUTYL-N-4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)
2CLTA:81-252; B:81-252CRYSTAL STRUCTURE OF THE ACTIVE FORM (FULL-LENGTH) OF HUMAN FIBROBLAST COLLAGENASE.
2JSDA:SOLUTION STRUCTURE OF MMP20 COMPLEXED WITH NNGH
2W0DA:; B:; C:; D:DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES.
2Y6CA:THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER
2Y6DA:THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER
3F15A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (S)-N-(2,3-DIHYDROXYPROPYL)-4-METHOXY-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE
3F16A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-N-(3-HYDROXY-1-NITROSO-1-OXOPROPAN-2-YL)-4-METHOXYBENZENESULFONAMIDE
3F17A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-(2-NITROSO-2-OXOETHYL) BIPHENYL-4-SULFONAMIDE
3F18A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR 4-FLUORO-N-(2-HYDROXYETHYL)-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE
3F19A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR 4-FLUORO-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE
3F1AA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-(2-NITROSO-2-OXOETHYL) BENZENESULFONAMIDE
3LK8A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR PARAMETHOXY-SULFONYL-GLYCINE HYDROXAMATE
3LKAA:CATALYTIC DOMAIN OF HUMAN MMP-12 COMPLEXED WITH HYDROXAMIC ACID AND PARAMETHOXY-SULFONYL AMIDE
3MA2A:; D:COMPLEX MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) WITH TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1)
3NX7A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-(2-HYDROXYETHYL)4-METHOXYPHENYLSULFONAMIDO)ACETAMIDE
3TS4A:HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
3TSKA:HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
3TT4A:HUMAN MMP8 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
3UVCA:; B:MMP12 IN A COMPLEX WITH THE DIMERIC ADDUCT: 5-(5-PHENYLHYDANTOIN)-5-PHENYLHYDANTOIN
3V96B:COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1)
4EFSA:HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
4GQLA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470.1
4GR0A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470B
4GR3A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470A
4GR8A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470C
4H30A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
4H49A:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR.
4H76A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A BROAD SPECTRUM HYDROXAMATE INHIBITOR
4H84A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A SELECTIVE CARBOXYLATE BASED INHIBITOR.
4I03A:HUMAN MMP12 IN COMPLEX WITH A PEG-LINKED BIFUNCTIONAL L-GLUTAMATE MOTIF INHIBITOR
4ILWD:; F:COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2)
(-)
Protein domain: Collagenase-3 (MMP-13) (31)
(-)
Human (Homo sapiens) [TaxId: 9606] (30)
1EUBA:SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR
1FLSA:SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
1FM1A:SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR
1XUCA:; B:MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
1XUDA:; B:MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
1XURA:; B:MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR
1YOUA:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR
1ZTQA:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033
2D1NA:; B:COLLAGENASE-3 (MMP-13) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR
2E2DA:FLEXIBILITY AND VARIABILITY OF TIMP BINDING: X-RAY STRUCTURE OF THE COMPLEX BETWEEN COLLAGENASE-3/MMP-13 AND TIMP-2
2OW9A:; B:CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR
2OZRA:; B:; C:; D:; E:; F:; G:; H:MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
2PJTA:; B:; C:; D:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344
2YIGA:; B:MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR
3ELMA:; B:CRYSTAL STRUCTURE OF MMP-13 COMPLEXED WITH INHIBITOR 24F
3I7GA:; B:MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR
3I7IA:; B:MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR
3KECA:; B:CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A PHENYL-2H-TETRAZOLE COMPOUND
3KEJA:; B:CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H-TETRAZOLE COMPOUND
3KEKA:; B:CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H-TETRAZOLE COMPOUND
3KRYA:; B:; C:; D:CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080
3LJZA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND
3O2XA:; B:; C:; D:MMP-13 IN COMPLEX WITH SELECTIVE TETRAZOLE CORE INHIBITOR
3TVCA:HUMAN MMP13 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR
3ZXHA:; B:MMP-13 COMPLEXED WITH 2-NAPTHYLSULFONAMIDE HYDROXAMIC ACID INHIBITOR
456CA:; B:CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
4A7BA:; B:MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22
4JP4A:; B:MMP13 IN COMPLEX WITH A REVERSE HYDROXAMATE ZN-BINDER
4JPAA:; B:MMP13 IN COMPLEX WITH A PIPERAZINE HYDANTOIN LIGAND
830CA:; B:COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1CXVA:; B:STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13)
(-)
Protein domain: Fibroblast collagenase (MMP-1) (14)
(-)
Human (Homo sapiens) [TaxId: 9606] (13)
1AYKA:INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, 30 STRUCTURES
1CGEA:CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF
1CGFA:; B:CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF
1CGLA:; B:STRUCTURE OF THE CATALYTIC DOMAIN OF FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
1HFCA:1.56 ANGSTROM STRUCTURE OF MATURE TRUNCATED HUMAN FIBROBLAST COLLAGENASE
1SU3A:107-270; B:107-270X-RAY STRUCTURE OF HUMAN PROMMP-1: NEW INSIGHTS INTO COLLAGENASE ACTION
2AYKA:INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, MINIMIZED AVERAGE STRUCTURE
2J0TA:; B:; C:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-1 IN COMPLEX WITH THE INHIBITORY DOMAIN OF TIMP-1
2TCLA:STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
3AYKA:CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, MINIMIZED AVERAGE STRUCTURE
3SHIA:; M:; G:CRYSTAL STRUCTURE OF HUMAN MMP1 CATALYTIC DOMAIN AT 2.2 A RESOLUTION
4AYKA:CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES
966CA:CRYSTAL STRUCTURE OF FIBROBLAST COLLAGENASE-1 COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID
(-)
Pig (Sus scrofa) [TaxId: 9823] (1)
1FBLA:100-271STRUCTURE OF FULL-LENGTH PORCINE SYNOVIAL COLLAGENASE (MMP1) REVEALS A C-TERMINAL DOMAIN CONTAINING A CALCIUM-LINKED, FOUR-BLADED BETA-PROPELLER
(-)
Protein domain: Gelatinase A (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
1CK7A:108-216,A:394-449GELATINASE A (FULL-LENGTH)
1EAKA:108-216,A:394-452; B:108-216,B:394-450; C:108-216,C:394-449; D:108-216,D:394-450CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT
1GXDA:79-187,A:365-421; B:79-187,B:365-421PROMMP-2/TIMP-2 COMPLEX
1QIBA:CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN
(-)
Protein domain: Gelatinase B (MMP-9) (13)
(-)
Human (Homo sapiens) [TaxId: 9606] (13)
1GKCA:; B:MMP9-INHIBITOR COMPLEX
1GKDA:; B:MMP9 ACTIVE SITE MUTANT-INHIBITOR COMPLEX
1L6JA:106-215,A:391-444CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B).
2OVXA:; B:MMP-9 ACTIVE SITE MUTANT WITH BARBITURATE INHIBITOR
2OVZA:; B:MMP-9 ACTIVE SITE MUTANT WITH PHOSPHINATE INHIBITOR
2OW0A:; B:MMP-9 ACTIVE SITE MUTANT WITH IODINE-LABELED CARBOXYLATE INHIBITOR
2OW1A:; B:MMP-9 ACTIVE SITE MUTANT WITH TRIFLUOROMETHYL HYDROXAMATE INHIBITOR
2OW2A:; B:MMP-9 ACTIVE SITE MUTANT WITH DIFLUORO BUTANOIC ACID INHIBITOR
4H1QA:; B:CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
4H2EA:; B:CRYSTAL STRUCTURE OF AN MMP TWIN INHIBITOR COMPLEXING TWO MMP-9 CATALYTIC DOMAINS
4H3XA:; B:CRYSTAL STRUCTURE OF AN MMP BROAD SPECTRUM HYDROXAMATE BASED INHIBITOR CC27 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
4H82A:; B:; C:; D:CRYSTAL STRUCTURE OF MUTANT MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A TWIN INHIBITOR.
4HMAA:; B:CRYSTAL STRUCTURE OF AN MMP TWIN CARBOXYLATE BASED INHIBITOR LC20 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
(-)
Protein domain: Macrophage elastase (MMP-12) (34)
(-)
Human (Homo sapiens) [TaxId: 9606] (34)
1JIZA:; B:CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP-12
1JK3A:CRYSTAL STRUCTURE OF HUMAN MMP-12 (MACROPHAGE ELASTASE) AT TRUE ATOMIC RESOLUTION
1OS2A:; B:; C:; D:; E:; F:TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12
1OS9A:; B:; C:; D:; E:; F:BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12
1RMZ  [entry was replaced by entry 5LAB without any SCOP domain information]
1ROSA:; B:CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID
1UTTA:CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID
1UTZA:; B:CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRI DIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID
1Y93A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH ACETOHYDROXAMIC ACID AT ATOMIC RESOLUTION
1YCMA:SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 12 (MMP12) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)
2HU6A:CRYSTAL STRUCTURE OF HUMAN MMP-12 IN COMPLEX WITH ACETOHYDROXAMIC ACID AND A BICYCLIC INHIBITOR
2K2GA:SOLUTION STRUCTURE OF THE WILD-TYPE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 12 (MMP-12) IN COMPLEX WITH A TIGHT-BINDING INHIBITOR
2K9CA:PARAMAGNETIC SHIFTS IN SOLID-STATE NMR OF PROTEINS TO ELICIT STRUCTURAL INFORMATION
2OXUA:UNINHIBITED FORM OF HUMAN MMP-12
2OXWA:HUMAN MMP-12 COMPLEXED WITH THE PEPTIDE IAG
2OXZA:HUMAN MMP-12 IN COMPLEX WITH TWO PEPTIDES PQG AND IAG
2POJA:106-263NMR SOLUTION STRUCTURE OF THE INHIBITOR-FREE STATE OF MACROPHAGE METALLOELASTASE (MMP-12)
2WO8A:; B:; C:; D:MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
2WO9A:; C:; D:; B:MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
2WOAA:; B:; C:; D:MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID
2Z2DA:106-263SOLUTION STRUCTURE OF HUMAN MACROPHAGE ELASTASE (MMP-12) CATALYTIC DOMAIN COMPLEXED WITH A GAMMA-KETO BUTANOIC ACID INHIBITOR
3BA0A:106-274CRYSTAL STRUCTURE OF FULL-LENGTH HUMAN MMP-12
3EHXA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-2-(BIPHENYL-4-YLSULFONAMIDO)-4-METHYLPENTANOIC ACID
3EHYA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-2-(4-METHOXYPHENYLSULFONAMIDO)PROPANOIC ACID
3LIKA:HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
3LILA:HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
3LIRA:HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
3LJGA:HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR
3N2UA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(4-METHOXY-N(2-(3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YLOXY)ETHYL)PHENYLSULFONAMIDO) ACETAMIDE
3N2VA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-HYDROXYETHYL)BIPHENYL-4-YLSULFONAMIDO)ACETAMIDE
3RTSA:HUMAN MMP-12 CATALYTIC DOMAIN IN COMPLEX WITH*N*-HYDROXY-2-(2-PHENYLETHYLSULFONAMIDO)ACETAMIDE
3RTTA:HUMAN MMP-12 CATALYTIC DOMAIN IN COMPLEX WITH*(R)-N*-HYDROXY-1-(PHENETHYLSULFONYL)PYRROLIDINE-2-CARBOXAMIDE
4GUYA:HUMAN MMP12 CATALYTIC DOMAIN IN COMPLEX WITH*N*-HYDROXY-2-(2-(4-METHOXYPHENYL)ETHYLSULFONAMIDO)ACETAMIDE
4IJOA:UNRAVELING HIDDEN ALLOSTERIC REGULATORY SITES IN STRUCTURALLY HOMOLOGUES METALLOPROTEASES
(-)
Protein domain: Matrilysin (MMP-7) (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1MMPA:; B:MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR
1MMQA:MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR
1MMRA:MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR
(-)
Protein domain: Matrix metalloproteinase-16 (MMP-16) (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1RM8A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-16/MT3-MMP: CHARACTERIZATION OF MT-MMP SPECIFIC FEATURES
(-)
Protein domain: Membrane-type matrix metalloproteinase (CDMT1-MMP) (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1BQQM:CRYSTAL STRUCTURE OF THE MT1-MMP--TIMP-2 COMPLEX
1BUVM:CRYSTAL STRUCTURE OF THE MT1-MMP-TIMP-2 COMPLEX
(-)
Protein domain: MMP-2 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1HOVA:SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020
(-)
Protein domain: Neutrophil collagenase (MMP-8) (22)
(-)
Human (Homo sapiens) [TaxId: 9606] (22)
1A85A:MMP8 WITH MALONIC AND ASPARAGINE BASED INHIBITOR
1A86A:MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR
1BZSA:CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909
1I73A:COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
1I76A:COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
1JANA:COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM)
1JAOA:COMPLEX OF 3-MERCAPTO-2-BENZYLPROPANOYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
1JAPA:COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
1JAQA:COMPLEX OF 1-HYDROXYLAMINE-2-ISOBUTYLMALONYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM)
1JH1A:CRYSTAL STRUCTURE OF MMP-8 COMPLEXED WITH A 6H-1,3,4-THIADIAZINE DERIVED INHIBITOR
1JJ9A:CRYSTAL STRUCTURE OF MMP8-BARBITURATE COMPLEX REVEALS MECHANISM FOR COLLAGEN SUBSTRATE RECOGNITION
1KBCA:; B:PROCARBOXYPEPTIDASE TERNARY COMPLEX
1MMBA:COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8
1MNCA:STRUCTURE OF HUMAN NEUTROPHIL COLLAGENASE REVEALS LARGE S1' SPECIFICITY POCKET
1ZP5A:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A N-HYDROXYUREA INHIBITOR
1ZS0A:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (S-ENANTIOMER)
1ZVXA:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (R-ENANTIOMER)
2OY2A:; F:HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG
2OY4A:; F:UNINHIBITED HUMAN MMP-8
3DNGA:; B:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON-ZINC CHELATING INHIBITOR
3DPEA:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON-ZINC CHELATING INHIBITOR
3DPFA:; B:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A NON-ZINC CHELATING INHIBITOR
(-)
Protein domain: Stromelysin-1 (MMP-3) (40)
(-)
Human (Homo sapiens), fibroblast [TaxId: 9606] (40)
1B3DA:; B:STROMELYSIN-1
1B8YA:X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY
1BIWA:; B:DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS
1BM6A:SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR, NMR, 20 STRUCTURES
1BQOA:; B:DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS
1C3IA:; B:HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812
1C8TA:; B:HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812
1CAQA:X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY
1CIZA:X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY
1CQRA:; B:CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION
1D5JA:; B:CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR.
1D7XA:; B:CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR.
1D8FA:; B:CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR.
1D8MA:; B:CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITOR
1G05A:; B:HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS
1G49A:; B:A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
1G4KA:; B:; C:X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN
1HFSA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004
1HY7A:; B:A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
1OO9A:ORIENTATION IN SOLUTION OF MMP-3 CATALYTIC DOMAIN AND N-TIMP-1 FROM RESIDUAL DIPOLAR COUPLINGS
1QIAA:; B:; C:; D:CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
1QICA:; B:; C:; D:CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN
1SLMA:81-250CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME
1SLNA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842
1UEAA:; C:MMP-3/TIMP-1 COMPLEX
1UMSA:STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES
1UMTA:STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR AVERAGE OF 20 STRUCTURES MINIMIZED WITH RESTRAINTS
1USNA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372
2D1OA:; B:STROMELYSIN-1 (MMP-3) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR
2JNPA:SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)
2JT5A:SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-HYDROXY-2-[N-(2-HYDROXYETHYL)BIPHENYL-4-SULFONAMIDE] HYDROXAMIC ACID (MLC88)
2JT6A:SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF 3-4'-CYANOBYPHENYL-4-YLOXY)-N-HDYDROXYPROPIONAMIDE (MMP-3 INHIBITOR VII)
2SRTA:CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR
2USNA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803
3OHLA:CATALYTIC DOMAIN OF STROMELYSIN-1 IN COMPLEX WITH N-HYDROXY-2-(4-METHOXY-N-(PYRIDINE-3-YLMETHYL)PHENYLSULFONAMIDO)ACETAMIDE
3OHOA:CATALYTIC DOMAIN OF STROMELYSIN-1 IN COMPLEX WITH N-HYDROXY-2-(4-METHYLPHENYLSULFONAMIDO)ACETAMIDE
3USNA:STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE
4DPEA:; B:STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR.
4G9LA:; B:STRUCTURE OF MMP3 COMPLEXED WITH NNGH INHIBITOR.
4JA1A:; B:STRUCTURE OF MMP3 COMPLEXED WITH A PLATINUM-BASED INHIBITOR
(-)
Protein domain: Stromelysin-2 (MMP-10) (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1Q3AA:; B:; C:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10
(-)
Protein domain: Stromelysin-3 (MMP-11) (1)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1HV5A:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF THE STROMELYSIN-3 (MMP-11) CATALYTIC DOMAIN COMPLEXED WITH A PHOSPHINIC INHIBITOR
(-)
Family: Neurolysin-like (55)
(-)
Protein domain: Angiotensin converting enzyme 2, ACE2 (10)
(-)
Human (Homo sapiens) [TaxId: 9606] (5)
1R42A:NATIVE HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE (ACE2)
1R4LA:INHIBITOR BOUND HUMAN ANGIOTENSIN CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE (ACE2)
2AJFA:; B:STRUCTURE OF SARS CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS RECEPTOR
3SCIA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM A PREDICTED SARS CORONAVIRUS HUMAN STRAIN COMPLEXED WITH HUMAN RECEPTOR ACE2
3SCJA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM A PREDICTED SARS CORONAVIRUS CIVET STRAIN COMPLEXED WITH HUMAN RECEPTOR ACE2
(-)
Paguma larvata (5)
3D0GA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM THE 2002-2003 SARS CORONAVIRUS HUMAN STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2
3D0HA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM THE 2002-2003 SARS CORONAVIRUS CIVET STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2
3D0IA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM THE 2005-2006 SARS CORONAVIRUS CIVET STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2
3SCKA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM A PREDICTED SARS CORONAVIRUS CIVET STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2
3SCLA:; B:CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR-BINDING DOMAIN FROM SARS CORONAVIRUS EPIDEMIC STRAIN COMPLEXED WITH HUMAN-CIVET CHIMERIC RECEPTOR ACE2
(-)
Protein domain: Angiotensin converting enzyme, ACE (14)
(-)
Fruit fly (Drosophila melanogaster) [TaxId: 7227] (3)
1J36A:; B:CRYSTAL STRUCTURE OF DROSOPHILA ANCE
1J37A:; B:CRYSTAL STRUCTURE OF DROSOPHILA ANCE
1J38A:; B:CRYSTAL STRUCTURE OF DROSOPHILA ANCE
(-)
Human (Homo sapiens) [TaxId: 9606] (11)
1O86A:CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH LISINOPRIL.
1O8AA:CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERTING ENZYME (NATIVE).
1UZEA:COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRILAT AND THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME
1UZFA:COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME
2OC2A:STRUCTURE OF TESTIS ACE WITH RXPA380
2XY9A:HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE
3BKKA:TESIS ACE CO-CRYSTAL STRUCTURE WITH KETONE ACE INHIBITOR KAF
3BKLA:TESTIS ACE CO-CRYSTAL STRUCTURE WITH KETONE ACE INHIBITOR KAW
3L3NA:TESTIS ACE CO-CRYSTAL STRUCTURE WITH NOVEL INHIBITOR LISW
4BZRA:HUMAN TESTIS ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH K-26
4CA5A:HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI
(-)
Protein domain: automated matches (25)
(-)
Fruit fly (Drosophila melanogaster) [TaxId: 7227] (15)
2X8YA:CRYSTAL STRUCTURE OF ANCE
2X8ZA:CRYSTAL STRUCTURE OF ANCE-CAPTOPRIL COMPLEX
2X90A:CRYSTAL STRUCTURE OF ANCE-ENALAPRILAT COMPLEX
2X91A:CRYSTAL STRUCTURE OF ANCE-LISINOPRIL COMPLEX
2X92A:CRYSTAL STRUCTURE OF ANCE-RAMIPRILAT COMPLEX
2X93A:CRYSTAL STRUCTURE OF ANCE-TRANDOLAPRILAT COMPLEX
2X94A:CRYSTAL STRUCTURE OF ANCE-PERINDOPRILAT COMPLEX
2X95A:CRYSTAL STRUCTURE OF ANCE-LISINOPRIL-TRYPTOPHAN ANALOGUE, LISW-S COMPLEX
2X96A:CRYSTAL STRUCTURE OF ANCE-RXPA380 COMPLEX
2X97A:CRYSTAL STRUCTURE OF ANCE-RXP407 COMPLEX
2XHMA:CRYSTAL STRUCTURE OF ANCE-K26 COMPLEX
3ZQZA:CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL
4AA1A:CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH ANGIOTENSIN-II
4CA7A:DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI
4CA8A:DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FII
(-)
Human (Homo sapiens) [TaxId: 9606] (8)
2IULA:HUMAN TACE G13 MUTANT
2IUXA:HUMAN TACE MUTANT G1234
2YDMA:STRUCTURAL CHARACTERIZATION OF ANGIOTENSIN-I CONVERTING ENZYME IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL
4C2NA:CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT E403R
4C2OA:CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT D465T
4C2PA:CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522K IN COMPLEX WITH CAPTOPRIL
4C2QA:CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522K
4C2RA:CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-I CONVERTING ENZYME MUTANT R522Q
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (2)
2O3EA:CRYSTAL STRUCTURE OF ENGINEERED NEUROLYSIN WITH THIMET OLIGOPEPTIDASE SPECIFICITY FOR NEUROTENSIN CLEAVAGE SITE.
4FXYP:; Q:CRYSTAL STRUCTURE OF RAT NEUROLYSIN WITH BOUND PYRAZOLIDIN INHIBITOR
(-)
Protein domain: Neurolysin (endopeptidase 24.16, thimet oligopeptidase) (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1S4BP:CRYSTAL STRUCTURE OF HUMAN THIMET OLIGOPEPTIDASE.
2O36A:CRYSTAL STRUCTURE OF ENGINEERED THIMET OLIGOPEPTIDASE WITH NEUROLYSIN SPECIFICITY IN NEUROTENSIN CLEAVAGE SITE
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1I1IP:NEUROLYSIN (ENDOPEPTIDASE 24.16) CRYSTAL STRUCTURE
(-)
Protein domain: Thermostable carboxypeptidase 1 (3)
(-)
Pyrococcus furiosus [TaxId: 2261] (3)
1K9XA:; B:; C:; D:STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE APO-YB
1KA2A:STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE APO-MG
1KA4A:STRUCTURE OF PYROCOCCUS FURIOSUS CARBOXYPEPTIDASE NAT-PB
(-)
Family: Neutral endopeptidase (neprilysin) (7)
(-)
Protein domain: automated matches (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2YB9A:CRYSTAL STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH A HETEROARYLALANINE DIACID.
(-)
Protein domain: Neutral endopeptidase (neprilysin) (6)
(-)
Human (Homo sapiens) [TaxId: 9606] (6)
1DMTA:STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH PHOSPHORAMIDON
1R1HA:STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS
1R1IA:STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS
1R1JA:STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS
1Y8JA:CRYSTAL STRUCTURE OF HUMAN NEP COMPLEXED WITH AN IMIDAZO[4,5-C]PYRIDINE INHIBITOR
2QPJA:HUMAN NEP COMPLEXED WITH A BIFUNCTIONAL NEP/DPP IV INHIBITOR
(-)
Family: Predicted metal-dependent hydrolase (4)
(-)
Protein domain: automated matches (1)
(-)
Haemophilus influenzae [TaxId: 727] (1)
1XAXA:NMR STRUCTURE OF HI0004, A PUTATIVE ESSENTIAL GENE PRODUCT FROM HAEMOPHILUS INFLUENZAE
(-)
Protein domain: Hypothetical protein Aq_1354 (1)
(-)
Aquifex aeolicus [TaxId: 63363] (1)
1OZ9A:CRYSTAL STRUCTURE OF AQ_1354, A HYPOTHETICAL PROTEIN FROM AQUIFEX AEOLICUS
(-)
Protein domain: Hypothetical protein TM1509 (1)
(-)
Thermotoga maritima [TaxId: 2336] (1)
1TVIA:SOLUTION STRUCTURE OF TM1509 FROM THERMOTOGA MARITIMA: VT1, A NESGC TARGET PROTEIN
(-)
Protein domain: Hypothetical protein YbeY (1)
(-)
Escherichia coli [TaxId: 562] (1)
1XM5A:; B:; C:; D:CRYSTAL STRUCTURE OF METAL-DEPENDENT HYDROLASE YBEY FROM E. COLI, PFAM UPF0054
(-)
Family: Reprolysin-like (24)
(-)
Protein domain: ADAM33 (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1R54A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM33
1R55A:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33
(-)
Protein domain: automated matches (2)
(-)
Bothrops moojeni [TaxId: 98334] (1)
3GBOA:CRYSTAL STRUCTURE OF BMOOMPALPHA-I, A NON-HEMORRHAGIC METALLOPROTEINASE ISOLATED FROM BOTHROPS MOOJENI SNAKE VENOM
(-)
Sharp-nosed viper (Deinagkistrodon acutus) [TaxId: 36307] (1)
1YP1A:CRYSTAL STRUCTURE OF A NON-HEMORRHAGIC FIBRIN(OGEN)OLYTIC METALLOPROTEINASE FROM VENOM OF AGKISTRODON ACUTUS
(-)
Protein domain: Snake venom metalloprotease (20)
(-)
Chinese five-pace snake (Agkistrodon acutus), acutolysin C [TaxId: 36307] (1)
1QUAA:CRYSTAL STRUCTURE OF ACUTOLYSIN-C, A HEMORRHAGIC TOXIN FROM THE SNAKE VENOM OF AGKISTRODON ACUTUS, AT 2.2 A RESOLUTION
(-)
Eastern diamondback rattlesnake (Crotalus adamanteus), adamalysin II [TaxId: 8729] (4)
1IAGA:FIRST STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE: A PROTOTYPE FOR MATRIX METALLOPROTEINASES(SLASH)COLLAGENASES
2AIGP:ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL647
3AIGA:ADAMALYSIN II WITH PEPTIDOMIMETIC INHIBITOR POL656
4AIGA:ADAMALYSIN II WITH PHOSPHONATE INHIBITOR
(-)
Five-pace snake (Agkistrodon acutus), acutolysin A [TaxId: 36307] (2)
1BSWA:ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 7.5
1BUDA:ACUTOLYSIN A FROM SNAKE VENOM OF AGKISTRODON ACUTUS AT PH 5.0
(-)
Habu (Trimeresurus flavoviridis), Trimerelysin II [TaxId: 88087] (1)
1WNIA:CRYSTAL STRUCTURE OF H2-PROTEINASE
(-)
Taiwan habu (Trimeresurus mucrosquamatus), atrolysin E [TaxId: 103944] (4)
1KUFA:HIGH-RESOLUTION CRYSTAL STRUCTURE OF A SNAKE VENOM METALLOPROTEINASE FROM TAIWAN HABU
1KUGA:CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH ITS ENDOGENOUS INHIBITOR PENW
1KUIA:CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEQW.
1KUKA:CRYSTAL STRUCTURE OF A TAIWAN HABU VENOM METALLOPROTEINASE COMPLEXED WITH PEKW.
(-)
Terciopelo (Bothrops asper), bap1 [TaxId: 8722] (5)
1ND1A:AMINO ACID SEQUENCE AND CRYSTAL STRUCTURE OF BAP1, A METALLOPROTEINASE FROM BOTHROPS ASPER SNAKE VENOM THAT EXERTS MULTIPLE TISSUE-DAMAGING ACTIVITIES.
2W12A:HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
2W13A:HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
2W14A:HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
2W15A:HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING
(-)
Western diamonback rattlesnake (Crotalus atrox), atrolysin C [TaxId: 8730] (3)
1ATLA:; B:STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE, ATROLYSIN C (FORM-D)
1DTHA:; B:METALLOPROTEASE
1HTDA:; B:STRUCTURAL INTERACTION OF NATURAL AND SYNTHETIC INHIBITORS WITH THE VENOM METALLOPROTEINASE, ATROLYSIN C (HT-D)
(-)
Family: Serralysin-like metalloprotease, catalytic (N-terminal) domain (25)
(-)
Protein domain: automated matches (1)
(-)
Flavobacterium sp. [TaxId: 686394] (1)
3U1RA:20-261STRUCTURE ANALYSIS OF A NEW PSYCHROPHILIC MARINE PROTEASE
(-)
Protein domain: Metalloprotease (24)
(-)
Erwinia chrysanthemi [TaxId: 556] (9)
1GO7P:18-258THE METZINCIN'S METHIONINE: PRTC M226C-E189K DOUBLE MUTANT
1GO8P:20-258THE METZINCIN'S METHIONINE: PRTC M226L MUTANT
1K7GA:25-258PRTC FROM ERWINIA CHRYSANTHEMI
1K7IA:18-258PRTC FROM ERWINIA CHRYSANTHEMI: Y228F MUTANT
1K7QA:18-258PRTC FROM ERWINIA CHRYSANTHEMI: E189A MUTANT
3HB2P:18-258PRTC METHIONINE MUTANTS: M226I
3HBUP:18-258PRTC METHIONINE MUTANTS: M226H DESY
3HBVP:61-258PRTC METHIONINE MUTANTS: M226A IN-HOUSE
3HDAP:61-258PRTC METHIONINE MUTANTS: M226A_DESY
(-)
Pseudomonas aeruginosa [TaxId: 287] (3)
1AKLA:1-246ALKALINE PROTEASE FROM PSEUDOMONAS AERUGINOSA IFO3080
1JIWP:1-246CRYSTAL STRUCTURE OF THE APR-APRIN COMPLEX
1KAPP:1-246THREE-DIMENSIONAL STRUCTURE OF THE ALKALINE PROTEASE OF PSEUDOMONAS AERUGINOSA: A TWO-DOMAIN PROTEIN WITH A CALCIUM BINDING PARALLEL BETA ROLL MOTIF
(-)
Pseudomonas sp., tac ii 18 [TaxId: 306] (8)
1G9KA:3-244CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18
1H71P:3-244PSYCHROPHILIC PROTEASE FROM PSEUDOALTEROMONAS 'TAC II 18'
1O0QA:3-244CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 1 MM EDTA
1O0TA:3-244CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5 MM EDTA (5 DAYS)
1OM6A:3-244CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLIZED WITH 5MM EDTA (2 MONTHS)
1OM7A:3-244CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, SOAKED IN 85 MM EDTA
1OM8A:3-244CRYSTAL STRUCTURE OF A COLD ADAPTED ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18, CO-CRYSTALLYZED WITH 10 MM EDTA
1OMJA:3-244CRYSTAL STRUCTURE OF A PSYCHROPHILIC ALKALINE PROTEASE FROM PSEUDOMONAS TAC II 18
(-)
Serratia marcescens [TaxId: 615] (4)
1AF0A:2-246SERRATIA PROTEASE IN COMPLEX WITH INHIBITOR
1SATA:4-246CRYSTAL STRUCTURE OF THE 50 KDA METALLO PROTEASE FROM S. MARCESCENS
1SMPA:4-246CRYSTAL STRUCTURE OF A COMPLEX BETWEEN SERRATIA MARCESCENS METALLO-PROTEASE AND AN INHIBITOR FROM ERWINIA CHRYSANTHEMI
1SRPA:4-246STRUCTURAL ANALYSIS OF SERRATIA PROTEASE
(-)
Family: Thermolysin-like (130)
(-)
Protein domain: Aureolysin (1)
(-)
Staphylococcus aureus [TaxId: 1280] (1)
1BQBA:AUREOLYSIN, STAPHYLOCOCCUS AUREUS METALLOPROTEINASE
(-)
Protein domain: automated matches (3)
(-)
Paenibacillus polymyxa [TaxId: 1406] (2)
4B52A:; B:CRYSTAL STRUCTURE OF GENTLYASE, THE NEUTRAL METALLOPROTEASE OF PAENIBACILLUS POLYMYXA
4GERA:; B:CRYSTAL STRUCTURE OF GENTLYASE, THE NEUTRAL METALLOPROTEASE OF PAENIBACILLUS POLYMYXA
(-)
Pseudoalteromonas sp. [TaxId: 234831] (1)
3NQYB:CRYSTAL STRUCTURE OF THE AUTOPROCESSED COMPLEX OF VIBRIOLYSIN MCP-02 WITH A SINGLE POINT MUTATION E346A
(-)
Protein domain: Elastase (3)
(-)
Pseudomonas aeruginosa [TaxId: 287] (3)
1EZMA:THREE-DIMENSIONAL STRUCTURE OF THE ELASTASE OF PSEUDOMONAS AERUGINOSA AT 1.5 ANGSTROMS RESOLUTION
1U4GA:ELASTASE OF PSEUDOMONAS AERUGINOSA WITH AN INHIBITOR
3DBKA:PSEUDOMONAS AERUGINOSA ELASTASE WITH PHOSPHORAMIDON
(-)
Protein domain: Neutral protease (2)
(-)
Bacillus cereus, strain dsm 3101 [TaxId: 1396] (2)
1ESPA:NEUTRAL PROTEASE MUTANT E144S
1NPCA:THE STRUCTURE OF NEUTRAL PROTEASE FROM BACILLUS CEREUS AT 0.2-NM RESOLUTION
(-)
Protein domain: Thermolysin (121)
(-)
Bacillus thermoproteolyticus [TaxId: 1427] (121)
1FJ3A:THERMOLYSIN (50% ACETONE SOAKED)
1FJOA:THERMOLYSIN (60% ACETONE SOAKED CRYSTALS)
1FJQA:THERMOLYSIN (70% ACETONE SOAKED CRYSTALS)
1FJTA:THERMOLYSIN (50% ACETONITRILE SOAKED CRYSTALS)
1FJUA:THERMOLYSIN (80% ACETONITRILE SOAKED CRYSTALS)
1FJVA:THERMOLYSIN (60% ACETONITRILE SOAKED CRYSTALS)
1FJWA:THERMOLYSIN (50 MM PHENOL SOAKED)
1GXWA:THE 2.2 A RESOLUTION STRUCTURE OF THERMOLYSIN CRYSTALLIZED IN PRESENCE OF POTASSIUM THIOCYANATE
1HYTA:RE-DETERMINATION AND REFINEMENT OF THE COMPLEX OF BENZYLSUCCINIC ACID WITH THERMOLYSIN AND ITS RELATION TO THE COMPLEX WITH CARBOXYPEPTIDASE A
1KEIA:THERMOLYSIN (SUBSTRATE-FREE)
1KJOA:THERMOLYSIN COMPLEXED WITH Z-L-THREONINE (BENZYLOXYCARBONYL-L-THREONINE)
1KJPA:THERMOLYSIN COMPLEXED WITH Z-L-GLUTAMIC ACID (BENZYLOXYCARBONYL-L-GLUTAMIC ACID)
1KKKA:THERMOLYSIN COMPLEXED WITH Z-L-ASPARTIC ACID (BENZYLOXYCARBONYL-L-ASPARTIC ACID)
1KL6A:THERMOLYSIN COMPLEXED WITH Z-L-ALANINE (BENZYLOXYCARBONYL-L-ALANINE)
1KR6A:THERMOLYSIN COMPLEXED WITH Z-D-GLUTAMIC ACID (BENZYLOXYCARBONYL-D-GLUTAMIC ACID)
1KROA:THERMOLYSIN COMPLEXED WITH Z-D-THREONINE (BENZYLOXYCARBONYL-D-THREONINE)
1KS7A:THERMOLYSIN COMPLEXED WITH Z-D-ASPARTIC ACID (BENZYLOXYCARBONYL-D-ASPARTIC ACID)
1KTOA:THERMOLYSIN COMPLEXED WITH Z-D-ALANINE (BENZYLOXYCARBONYL-D-ALANINE)
1L3FE:THERMOLYSIN IN THE ABSENCE OF SUBSTRATE HAS AN OPEN CONFORMATION
1LNAE:A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN
1LNBE:A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN
1LNCE:A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN
1LNDE:A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN
1LNEE:A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN
1LNFE:A STRUCTURAL ANALYSIS OF METAL SUBSTITUTIONS IN THERMOLYSIN
1OS0A:THERMOLYSIN WITH AN ALPHA-AMINO PHOSPHINIC INHIBITOR
1PE5A:THERMOLYSIN WITH TRICYCLIC INHIBITOR
1PE7A:THERMOLYSIN WITH BICYCLIC INHIBITOR
1PE8A:THERMOLYSIN WITH MONOCYCLIC INHIBITOR
1QF0A:THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYL-3-PHENYLPROPANOYL)-PHE-TYR. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE
1QF1A:THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYLHEPTANOYL)-PHE-ALA. PARAMETERS FOR ZN-BIDENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE
1QF2A:THERMOLYSIN (E.C.3.4.24.27) COMPLEXED WITH (2-SULPHANYL-3-PHENYLPROPANOYL)-GLY-(5-PHENYLPROLINE). PARAMETERS FOR ZN-MONODENTATION OF MERCAPTOACYLDIPEPTIDES IN METALLOENDOPEPTIDASE
1THLA:THERMOLYSIN COMPLEXED WITH A NOVEL GLUTARAMIDE DERIVATIVE, N-(1-(2(R, S)-CARBOXY-4-PHENYLBUTYL) CYCLOPENTYLCARBONYL)-(S)-TRYPTOPHAN
1TLIA:THERMOLYSIN (2% ISOPROPANOL SOAKED CRYSTALS)
1TLPE:CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN
1TLXA:THERMOLYSIN (NATIVE)
1TMNE:BINDING OF N-CARBOXYMETHYL DIPEPTIDE INHIBITORS TO THERMOLYSIN DETERMINED BY X-RAY CRYSTALLOGRAPHY. A NOVEL CLASS OF TRANSITION-STATE ANALOGUES FOR ZINC PEPTIDASES
1Y3GE:CRYSTAL STRUCTURE OF A SILANEDIOL PROTEASE INHIBITOR BOUND TO THERMOLYSIN
1Z9GE:CRYSTAL STRUCTURE ANALYSIS OF THERMOLYSIN COMPLEXED WITH THE INHIBITOR (R)-RETRO-THIORPHAN
1ZDPE:CRYSTAL STRUCTURE ANALYSIS OF THERMOLYSIN COMPLEXED WITH THE INHIBITOR (S)-THIORPHAN
2A7GE:ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH
2G4ZA:ANOMALOUS SUBSTRUCTURE OF THERMOLYSIN
2TLIA:THERMOLYSIN (5% ISOPROPANOL SOAKED CRYSTALS)
2TLXA:THERMOLYSIN (NATIVE)
2TMNE:CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN
2WHZA:DIPEPTIDE INHIBITORS OF THERMOLYSIN
2WI0A:DIPEPTIDE INHIBITORS OF THERMOLYSIN
3DNZA:THERMOLYSIN BY LB NANOTEMPLATE METHOD BEFORE HIGH X-RAY DOSE ON ESRF ID14-2 BEAMLINE
3DO0A:THERMOLYSIN BY CLASSICAL HANGING DROP METHOD AFTER HIGH X-RAY DOSE ON ESRF ID14-2 BEAMLINE
3DO1A:THERMOLYSIN BY CLASSICAL HANGING DROP METHOD BEFORE HIGH X-RAY DOSE ON ESRF ID14-2 BEAMLINE
3DO2A:THERMOLYSIN BY LB NANOTEMPLATE METHOD AFTER HIGH X-RAY DOSE ON ESRF ID14-2 BEAMLINE
3EIMA:METAL EXCHANGE IN THERMOLYSIN
3F28A:THERMOLYSIN INHIBITION
3F2PA:THERMOLYSIN INHIBITION
3FB0A:METAL EXCHANGE IN THERMOLYSIN
3FBOA:METAL EXCHANGE IN THERMOLYSIN
3FCQA:THERMOLYSIN INHIBITION
3FGDA:DRUGSCORE FP: THERMOYLSIN IN COMPLEX WITH FRAGMENT.
3FLFA:THERMOLYSIN INHIBITION
3FORA:THERMOLYSIN COMPLEXED WITH BNPA (2-BENZYL-3-NITRO PROPANOIC ACID AMIDE)
3FV4A:THERMOLYSIN INHIBITION
3FVPA:THERMOLYSIN INHIBITION
3FXPA:THERMOLYSIN INHIBITION
3FXSA:METAL EXCHANGE IN THERMOLYSIN
3LS7A:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH XENON
3MS3A:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH ANILINE
3MSAA:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH 3-BROMOPHENOL
3MSFA:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH UREA
3MSNA:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH N-METHYLUREA
3N21A:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH S-1,2-PROPANDIOL
3NN7A:CRYSTAL STRUCTURE OF THERMOLYSIN IN COMPLEX WITH 2-BROMOACETATE
3P7PE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 100K STRUCTURE A (0.1 MGY)
3P7QE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 100K STRUCTURE B (2.5 MGY)
3P7RE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 100K STRUCTURE C (4.9 MGY)
3P7SE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 100K STRUCTURE D (7.2 MGY)
3P7TE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 160K STRUCTURE A (0.1 MGY)
3P7UE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 160K STRUCTURE B (2.4 MGY)
3P7VE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 160K STRUCTURE C (4.8 MGY)
3P7WE:RADIATION DAMAGE STUDY OF THERMOLYSIN - 160K STRUCTURE D (7.1 MGY)
3QGOA:STRUCTURE OF THERMOLYSIN IN COMPLEX WITH L-PHENYLALANINE METHYLESTER
3QH1A:STRUCTURE OF THERMOLYSIN IN COMPLEX WITH N-BENZYLOXYCARBONYL-L-ASPARTIC ACID
3QH5A:STRUCTURE OF THERMOLYSIN IN COMPLEX WITH N-CARBOBENZYLOXY-L-ASPARTIC ACID AND L-PHENYLALANINE METHYL ESTER
3SSBA:; B:STRUCTURE OF INSECT METALLOPROTEINASE INHIBITOR IN COMPLEX WITH THERMOLYSIN
3T2HE:TETRAGONAL THERMOLYSIN IN THE PRESENCE OF TMAO
3T2IE:TETRAGONAL THERMOLYSIN IN THE PRESENCE OF SARCOSINE
3T2JE:TETRAGONAL THERMOLYSIN IN THE PRESENCE OF BETAINE
3T73A:THERMOLYSIN IN COMPLEX WITH UBTLN22
3T74A:THERMOLYSIN IN COMPLEX WITH UBTLN27
3T87A:THERMOLYSIN IN COMPLEX WITH UBTLN28
3T8CA:THERMOLYSIN IN COMPLEX WITH UBTLN30
3T8DA:THERMOLYSIN IN COMPLEX WITH UBTLN31
3T8FA:THERMOLYSIN IN COMPLEX WITH UBTLN34
3T8GA:THERMOLYSIN IN COMPLEX WITH UBTLN26
3T8HA:THERMOLYSIN IN COMPLEX WITH UBTLN29
3TLIA:THERMOLYSIN (10% ISOPROPANOL SOAKED CRYSTALS)
3TMNE:THE BINDING OF L-VALYL-L-TRYPTOPHAN TO CRYSTALLINE THERMOLYSIN ILLUSTRATES THE MODE OF INTERACTION OF A PRODUCT OF PEPTIDE HYDROLYSIS
3ZI6A:STRUCTURE OF THERMOLYSIN SOLVED BY SAD FROM DATA COLLECTED BY DIRECT DATA COLLECTION (DDC) USING THE GROB ROBOT GONIOMETER
4D91A:THERMOLYSIN IN COMPLEX WITH DMSO AND ACETATE
4D9WA:THERMOLYSIN IN COMPLEX WITH UBTLN32
4H57A:THERMOLYSIN INHIBITION
4MTWE:THERMOLYSIN IN COMPLEX WITH UBTLN36
4MWPE:THERMOLYSIN IN COMPLEX WITH UBTLN46
4MXJE:THERMOLYSIN IN COMPLEX WITH UBTLN35
4MZNE:THERMOLYSIN IN COMPLEX WITH UBTLN59
4N4EE:THERMOLYSIN IN COMPLEX WITH UBTLN58
4N5PE:THERMOLYSIN IN COMPLEX WITH UBTLN20
4N66E:THERMOLYSIN IN COMPLEX WITH UBTLN37
4OI5E:GLYCEROL-FREE STRUCTURE OF THERMOLYSIN IN COMPLEX WITH UBTLN58
4OW3A:THERMOLYSIN STRUCTURE DETERMINED BY FREE-ELECTRON LASER
4TLIA:THERMOLYSIN (25% ISOPROPANOL SOAKED CRYSTALS)
4TLNA:BINDING OF HYDROXAMIC ACID INHIBITORS TO CRYSTALLINE THERMOLYSIN SUGGESTS A PENTACOORDINATE ZINC INTERMEDIATE IN CATALYSIS
4TMNE:SLOW-AND FAST-BINDING INHIBITORS OF THERMOLYSIN DISPLAY DIFFERENT MODES OF BINDING. CRYSTALLOGRAPHIC ANALYSIS OF EXTENDED PHOSPHONAMIDATE TRANSITION-STATE ANALOGUES
5TLIA:THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS)
5TLNA:BINDING OF HYDROXAMIC ACID INHIBITORS TO CRYSTALLINE THERMOLYSIN SUGGESTS A PENTACOORDINATE ZINC INTERMEDIATE IN CATALYSIS
5TMNE:SLOW-AND FAST-BINDING INHIBITORS OF THERMOLYSIN DISPLAY DIFFERENT MODES OF BINDING. CRYSTALLOGRAPHIC ANALYSIS OF EXTENDED PHOSPHONAMIDATE TRANSITION-STATE ANALOGUES
6TLIA:THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS)
6TMNE:STRUCTURES OF TWO THERMOLYSIN-INHIBITOR COMPLEXES THAT DIFFER BY A SINGLE HYDROGEN BOND
7TLIA:THERMOLYSIN (90% ISOPROPANOL SOAKED CRYSTALS)
7TLNA:STRUCTURAL ANALYSIS OF THE INHIBITION OF THERMOLYSIN BY AN ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITOR
8TLIA:THERMOLYSIN (100% ISOPROPANOL SOAKED CRYSTALS)
8TLNE:STRUCTURAL COMPARISON SUGGESTS THAT THERMOLYSIN AND RELATED NEUTRAL PROTEASES UNDERGO HINGE-BENDING MOTION DURING CATALYSIS
(-)
Family: TNF-alpha converting enzyme, TACE, catalytic domain (22)
(-)
Protein domain: automated matches (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
2I47A:; B:; C:; D:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR
2OI0A:CRYSTAL STRUCTURE ANALYSIS 0F THE TNF-A COVERTING ENZYME (TACE) IN COMPLEXED WITH ARYL-SULFONAMIDE
(-)
Protein domain: TNF-alpha converting enzyme, TACE, catalytic domain (20)
(-)
Human (Homo sapiens) [TaxId: 9606] (20)
1BKCA:; C:; E:; I:CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)
1ZXCA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR
2A8HA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE SULFONAMIDE HYDROXAMATE INHIBITOR
2DDFA:; B:CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH TAPI-2
2FV5A:; B:CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682
2FV9A:; B:CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1
3B92A:NOVEL THIO-BASED TACE INHIBITORS PART 2: RATIONAL DESIGN, SYNTHESIS AND SAR OF THIOL-CONTANING ARYL SUFONES
3CKIA:CRYSTAL STRUCTURE OF THE TACE-N-TIMP-3 COMPLEX
3E8RA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR
3EDZA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR
3EWJA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH CARBOXYLATE INHIBITOR
3G42A:; B:; C:; D:CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR
3KMCA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE-BASED INHIBITOR
3KMEA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL-PYRROLIDINYL-TARTRATE INHIBITOR
3L0TA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR
3L0VA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST HYDANTOIN INHIBITOR OCCUPYING THE S1' POCKET
3LE9A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH INDAZOLINONE-PHENYL-HYDANTOIN INHIBITOR
3LEAA:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH ISOINDOLINONE-BIPHENYL-HYDANTOIN INHIBITOR
3LGPA:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH BENZIMIDAZOLYL-THIENYL-TARTRATE BASED INHIBITOR
3O64A:; B:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH 2-(2-AMINOTHIAZOL-4-YL)PYRROLIDINE-BASED TARTRATE DIAMIDES
(-)
Family: TTHA0227-like (2)
(-)
Protein domain: Uncharacterized protein Acel_2062 (1)
(-)
Acidothermus cellulolyticus [TaxId: 28049] (1)
3E11A:1-113; B:CRYSTAL STRUCTURE OF A PREDICTED ZINCIN-LIKE METALLOPROTEASE (ACEL_2062) FROM ACIDOTHERMUS CELLULOLYTICUS 11B AT 1.80 A RESOLUTION
(-)
Protein domain: Uncharacterized protein TTHA0227 (1)
(-)
Thermus thermophilus [TaxId: 274] (1)
2EJQA:2-108; B:CONSERVED HYPOTHETICAL PROTEIN (TTHA0227) FROM THERMO THERMOPHILUS HB8
(-)
Family: Zinc protease (3)
(-)
Protein domain: automated matches (1)
(-)
Streptomyces caespitosus [TaxId: 53502] (1)
4HX3A:; C:; E:; G:; I:; K:CRYSTAL STRUCTURE OF STREPTOMYCES CAESPITOSUS SERMETSTATIN IN COMPLEX WITH S. CAESPITOSUS SNAPALYSIN
(-)
Protein domain: Zinc protease (2)
(-)
Streptomyces caespitosus [TaxId: 53502] (2)
1C7KA:CRYSTAL STRUCTURE OF THE ZINC PROTEASE
1KUHA:ZINC PROTEASE FROM STREPTOMYCES CAESPITOSUS
(-)
Family: Zn aminopeptidase catalytic domain (49)
(-)
Protein domain: Aminopeptidase N (APN) catalytic domain (1)
(-)
Neisseria meningitidis [TaxId: 122586] (1)
2GTQA:189-438CRYSTAL STRUCTURE OF AMINOPEPTIDASE N FROM HUMAN PATHOGEN NEISSERIA MENINGITIDIS
(-)
Protein domain: ERAP1 catalytic domain (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2YD0A:255-529CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 ERAP1
(-)
Protein domain: Leukotriene A4 hydrolase catalytic domain (45)
(-)
Human (Homo sapiens) [TaxId: 9606] (45)
1GW6A:209-460STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT
1H19A:209-460STRUCTURE OF [E271Q] LEUKOTRIENE A4 HYDROLASE
1HS6A:209-460STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN.
1SQMA:209-460STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE
2R59A:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR RB3041
2VJ8A:209-460COMPLEX OF HUMAN LEUKOTRIENE A4 HYDROLASE WITH A HYDROXAMIC ACID INHIBITOR
3B7RL:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR RB3040
3B7SA:209-460[E296Q]LTA4H IN COMPLEX WITH RSR SUBSTRATE
3B7TA:209-460[E296Q]LTA4H IN COMPLEX WITH ARG-ALA-ARG SUBSTRATE
3B7UX:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH KELATORPHAN
3CHOA:209-460CRYSTAL STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH 2-AMINO-N-[4-(PHENYLMETHOXY)PHENYL]-ACETAMIDE
3CHPA:209-460CRYSTAL STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH (3S)-3-AMINO-4-OXO-4-[(4-PHENYLMETHOXYPHENYL) AMINO]BUTANOIC ACID
3CHQA:209-460CRYSTAL STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH N5-[4-(PHENYLMETHOXY)PHENYL]-L-GLUTAMINE
3CHRA:209-460CRYSTAL STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH 4-AMINO-N-[4-(PHENYLMETHOXY)PHENYL]-BUTANAMIDE
3CHSA:209-460CRYSTAL STRUCTURE OF LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH (2S)-2-AMINO-5-[[4-[(2S)-2-HYDROXY-2-PHENYL-ETHOXY]PHENYL]AMINO]-5-OXO-PENTANOIC ACID
3FH5A:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR (2R)-2-[(4-BENZYLPHENOXY)METHYL]PYRROLIDINE.
3FH7A:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR 4-[(2S)-2-{[4-(4-CHLOROPHENOXY)PHENOXY]METHYL}PYRROLIDIN-1-YL]BUTANOATE.
3FH8A:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR 1-[2-(4-BENZYLPHENOXY)ETHYL]PYRROLIDINE.
3FHEA:209-460LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR N-[3-(4-BENZYLPHENOXY)PROPYL]-N-METHYL-BETA-ALANINE.
3FTSA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH RESVERATROL
3FTUA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH DIHYDRORESVERATROL
3FTVA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT N-(PYRIDIN-3-YLMETHYL)ANILINE
3FTWA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENTS N-(PYRIDIN-3-YLMETHYL)ANILINE AND ACETATE
3FTXA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH DIHYDRORESVERATROL AND BESTATIN
3FTYA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 3-(BENZYLOXY)PYRIDIN-2-AMINE
3FTZA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 2-(PYRIDIN-3-YLMETHOXY)ANILINE
3FU0A:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 4-(4-FLUOROBENZOYL)PYRIDINE
3FU3A:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 4-(2-AMINO-1,3-THIAZOL-4-YL)PHENOL
3FU5A:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH (5-THIOPHEN-2-YLTHIOPHEN-2-YL)METHYLAMINE
3FU6A:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT (4-THIOPHEN-2-YLPHENYL)METHANAMINE
3FUDA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH N-METHYL-1-(2-THIOPHEN-2-YLPHENYL)METHANAMINE
3FUEA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 5-CHLOROINDOLE AND BESTATIN
3FUFA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 5-FLUOROINDOLE AND BESTATIN
3FUHA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH FRAGMENT 5-HYDROXYINDOLE AND BESTATIN
3FUIA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH N-BENZYL-4-[(2R)-PYRROLIDIN-2-YLMETHOXY]ANILINE
3FUJA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH 5-[2-(1H-PYRROL-1-YL)ETHOXY]-1H-INDOLE
3FUKA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH 1-[2-(1H-INDOL-5-YLOXY)ETHYL]PIPERIDINE-4-CARBOXYLIC ACID
3FULA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH PYRIDIN-4-YL[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]METHANONE
3FUMA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH (R)-PYRIDIN-4-YL[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]METHANOL
3FUNA:209-460LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH {4-[(2R)-PYRROLIDIN-2-YLMETHOXY]PHENYL}(4-THIOPHEN-3-YLPHENYL) METHANONE
3U9WA:1209-1460STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH INHIBITOR SC57461A
4DPRA:209-460STRUCTURE OF HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH INHIBITOR CAPTOPRIL
4L2LA:209-460HUMAN LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH LIGAND 4-(4-BENZYLPHENYL)THIAZOL-2-AMINE
4MKTA:209-460HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH PRO-GLY-PRO ANALOGUE AND 4-(4-BENZYLPHENYL)THIAZOL-2-AMINE
4MS6A:209-460HUMAN LEUKOTRIENE A4 HYDROLASE IN COMPLEX WITH PRO-GLY-PRO ANALOGUE
(-)
Protein domain: Tricorn protease interacting factor F3 catalytic domain (2)
(-)
Thermoplasma acidophilum [TaxId: 2303] (2)
1Z1WA:171-414CRYSTAL STRUCTURES OF THE TRICORN INTERACTING FACOR F3 FROM THERMOPLASMA ACIDOPHILUM, A ZINC AMINOPEPTIDASE IN THREE DIFFERENT CONFORMATIONS
1Z5HA:171-414; B:171-414CRYSTAL STRUCTURES OF THE TRICORN INTERACTING FACTOR F3 FROM THERMOPLASMA ACIDOPHILUM